- GlobeNewswire•19 days ago
NORTHVALE, N.J., April 04, 2017-- Elite Pharmaceuticals, Inc. today announced that it had filed an Abbreviated New Drug Application with the US Food and Drug Administration for a generic version of a synthetic ...
- Capital Cube•last month
Categories: Yahoo Finance Get free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Pfizer Inc., Albany Molecular Research, Inc. and Akorn, Inc. (MYL-US, CBM-US, ACET-US, NKTR-US, PFE-US, AMRI-US and ... Read more (Read more...)
- GlobeNewswire•last month
NORTHVALE, N.J., March 13, 2017-- Elite Pharmaceuticals, Inc., announced today that it has initiated pharmacokinetic testing of its reformulated SequestOx™. The reformulated product is expected to have ...
ELTP : Summary for ELITE PHARMACEUTIC COM USD0.01 - Yahoo Finance
Elite Pharmaceuticals, Inc. (ELTP)
OTC BB - OTC BB Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.14 - 0.15|
|52 Week Range||0.11 - 0.40|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||4.70|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|